Understanding heart failure in patients with hypertrophic cardiomyopathy through advanced imaging techniques.
Unraveling The Mechanism of Heart Failure in Hypertrophic Cardiomyopathy with Exercise CMR
This study is looking at how heart failure happens in people with hypertrophic cardiomyopathy (HCM) and how a new medication called mavacamten might help, using special heart scans to understand their condition better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11029028 on NIH RePORTER |
What this research studies
This research investigates the mechanisms of heart failure in patients with hypertrophic cardiomyopathy (HCM) using cardiac magnetic resonance imaging (CMR). By employing advanced imaging techniques, the study aims to better characterize the different phenotypes of HCM and their response to treatment with a newly approved medication, mavacamten. The research will focus on evaluating heart function, fibrosis, and other critical factors that contribute to heart failure symptoms. Patients may undergo CMR scans to gather detailed information about their heart condition and how it may improve with treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with hypertrophic cardiomyopathy, particularly those experiencing heart failure symptoms.
Not a fit: Patients with hypertrophic cardiomyopathy who do not exhibit heart failure symptoms may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients with hypertrophic cardiomyopathy, potentially enhancing their quality of life and reducing heart failure complications.
How similar studies have performed: Previous research has shown promising results using cardiac magnetic resonance imaging to assess heart conditions, indicating that this approach may yield valuable insights into hypertrophic cardiomyopathy.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Nezafat, Reza — Beth Israel Deaconess Medical Center
- Study coordinator: Nezafat, Reza
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.